Im Cannabis (NASDAQ: IMCC) — Perfil da empresa, notícias e dados financeiros
Im Cannabis focuses on producing medical and recreational cannabis products, striving for quality and regulatory compliance.
Im Cannabis
Im Cannabis (CNSX:IMCC), (NASDAQ:IMCC) is a multi-faceted company deeply rooted in the medical and adult-use recreational cannabis industry. The company is recognized for its commitment to quality, regulatory compliance, and innovative operations across its international footprint. IM Cannabis focuses on producing and distributing a wide array of cannabis products, aiming to meet the diverse needs of its customer base. Additionally, the company actively pursues research and development projects aimed at creating new cannabis varieties and product formulations, underscoring its dedication to industry advancement and customer satisfaction. Through strategic acquisitions and partnerships, IM Cannabis strives to expand its market presence and adapt to the evolving cannabis landscape, with the ultimate objective of delivering substantial value to consumers and stakeholders alike.
Resumo
Operações
Produtos e/ou serviços de Im Cannabis
- Medical cannabis products offering a range of marijuana strains for various therapeutic purposes.
- Recreational cannabis lines tailored for different user experiences and preferences.
- International export services facilitating the distribution of medical cannabis products to global markets.
- Cannabis genetics and cultivation research to develop unique strains and improve product quality.
- Pharmaceutical-grade processing facilities ensuring high-quality cannabis products.
- Cannabis education and advocacy programs promoting responsible use and awareness of the benefits of cannabis.
equipe executiva do Im Cannabis
- Oren ShusterCEO & Executive Director
- Asi LeviChief Financial Officer
- Richard BallaChief Executive Officer of Adjupharm
- Anna TarankoDirector Investor & Public Relations
- Eyal FisherChief Executive Officer of the IMC Holdings
Últimas notícias sobre a Im Cannabis
IM Cannabis completes sale of IMC Holdings to Slil
United StatesIM Cannabis signs LOI for 51% SDI stake
United StatesIM Cannabis sells IMC Holdings clearing C$9.4 million
United StatesIM Cannabis to sell European assets
United StatesIM Cannabis explores U.S. market entry following Trump’s rescheduling directive
United States
Principais indicadores financeiros
Resultados divulgados pela Im Cannabis , em CAD.
- Cap. de mercado
- 1,4 mi
- Receita (TTM)
- 45,8 mi
- P/L
- —
- LPA (diluído, TTM)
- -73.1
- Dividend yield
- —
- Margem de lucro
- -39.1%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 54,7 mi | -11,6 mi | -11,3 mi | |
| 54 mi | -10,2 mi | -10,6 mi | |
| 48,8 mi | -12,8 mi | -9,5 mi | |
| 54,3 mi | -30,8 mi | -188,9 mi |